Daiichi SankyoDAIICHI SANKYO COMPANY, LIMITED4568東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Revenue changed +25.3% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and ending equity; net assets approximate parent equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2018 | — | —× | 3.2% | —× | — |
| 2019 | 10.0% | 0.47× | 4.7% | 1.59× | 7.5% |
| 2022 | — | —× | 3.0% | —× | — |
| 2023 | — | —× | 4.6% | —× | — |
| 2024 | 12.5% | 0.54× | 6.7% | 1.77× | 11.9% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Revenue | 960,195 | 929,717 | 1,044,892 | 1,278,478 | 1,601,688 |
| Cost of revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| SG&A | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Pretax income | 81,021 | 85,831 | 73,516 | 126,854 | 237,234 |
| Income tax | — | — | — | — | — |
| Net income attributable to owners | 60,282 | 93,409 | 66,972 | 109,188 | 200,731 |
| Operating margin | — | — | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Mar 2018 | FY ending Mar 2019 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥357.7B | ¥243.2B | ¥662.5B | ¥441.9B | ¥647.2B |
| Total assets | ¥1.9T | ¥2.09T | ¥2.22T | ¥2.51T | ¥3.46T |
| Net assets | — | ¥1.25T | — | — | ¥1.69T |
EDINET (FSA Japan)
訂正有価証券報告書－第21期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第18期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第17期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第16期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.